Session: Model Based Integrated Design of Pharmaceutical Drug Product and Process (2010 Annual Meeting)

Monday, November 8, 2010: 12:30 PM

Grand Ballroom B (Salt Palace Convention Center)

Description:

This session would specifically focus on work where a modeling approache coupled with optimization techniques are used in some decision making during the design of a pharmaceutical drug product and its process. This is an area of great interest from a Quality by Design perspective; and the use of modeling technology is an important trend in our business.

Sponsor:

Topical i : Comprehensive Quality by Design in Pharmaceutical Development and Manufacture

Co-Sponsor(s):

Systems and Process Design (10A), Pharmaceuticals (15b)

Chair:

Salvador Garcia-Munoz
Email: Salvador.Garcia-Munoz@pfizer.com

Co-Chair:

Nick Sahinidis
Email: sahinidis@cmu.edu

12:30 PM

(108a) Implementation of Novel Integrated Pharmaceutical Processes: A Model-Based Approach
Alicia Román Martínez, Rafiqul Gani and John M. Woodley

12:55 PM

(108b) Design Space of Pharmaceutical Processes Using Data-Driven Based Methods
Fani Boukouvala, Fernando J. Muzzio and Marianthi G. Ierapetritou

1:20 PM

(108c) Model Based Control of Drug Substance Particle Size to Ensure Drug Product Uniformity
Jon Hilden, Mark Schrad, Jessica T. Sloan, Jennifer Kuehne-Willmore and Timothy Kramer

1:45 PM

(108d) Modeling the Roll Compaction Process Using Finite Element Analysis
Ariel Muliadi, Carl R. Wassgren and James D. Litster

2:10 PM

(108e) Application of Model Based Drug Substance Particle Size Control in Drug Product Development
Mark Schrad, Jon Hilden, Jessica T. Sloan and Jennifer Kuehne-Willmore

2:35 PM

(108f) Investigation of a Tablet Coating Process Using a Multi-Model Simulation Approach
Daniele Suzzi, Gregor Toschkoff, Daniel Machold and Johannes Khinast

See more of this Group/Topical: Topical i : Comprehensive Quality by Design in Pharmaceutical Development and Manufacture

<< Previous Session | Next Session >>